2227029-18-5

2227029-18-5 structure
2227029-18-5 structure
  • Name: TUS-007
  • Chemical Name: TUS-007
  • CAS Number: 2227029-18-5
  • Molecular Formula: C44H54Cl2N8O5
  • Molecular Weight: 845.86
  • Catalog: Signaling Pathways GPCR/G Protein Ras
  • Create Date: 2023-04-12 18:38:28
  • Modify Date: 2024-04-07 10:03:36
  • TUS-007 is a CANDDY molecular, modified from a proteasome inhibitor. However, TUS-007 hardly inhibits proteasome activity. TUS-007 is also an orally active and potent KRAS G12D/V degrader. TUS-007 can be applied in KRAS G12D/V chemical knockdown in cell-free. TUS-007 also exhibits tumor suppression[1]. Note: CANDDY refers to Chemical knockdown with Affinity aNd Degradation DYnamics.

Name TUS-007
Description TUS-007 is a CANDDY molecular, modified from a proteasome inhibitor. However, TUS-007 hardly inhibits proteasome activity. TUS-007 is also an orally active and potent KRAS G12D/V degrader. TUS-007 can be applied in KRAS G12D/V chemical knockdown in cell-free. TUS-007 also exhibits tumor suppression[1]. Note: CANDDY refers to Chemical knockdown with Affinity aNd Degradation DYnamics.
Related Catalog
Target

KRas G12D

KRas G12V

In Vitro TUS-007 具有显著的靶向作用,对表达 KRAS G12D/V 的细胞具有毒性[1]。 TUS-007 (100 μM; 72 h) 选择性地降低表达 KRAS G12D/V 的低 RAS 小鼠胚胎成纤维细胞 (MEF) 的活力,而不是影响 KRAS G12C[1]。 TUS-007 (20-160 μM; 72 h) 可增加 annexin V 阳性的 SW1990 细胞的凋亡比例[1]。 Apoptosis Analysis[1] Cell Line: SW1990 cells Concentration: 20 μM, 40 μM, 80 μM, and 60 μM Incubation Time: 72 hours Result: Increased the proportion of annexin V-positive apoptotic SW1990 cells compared with those treated with DMSO or RAS-SOS-NH2.
In Vivo TUS-007 (80 mg/kg 腹腔注射或 160 mg/kg 口服;每 3 天 1 次,共 21 天) 在 SW620-Luc 异种移植小鼠模型中,对 KRAS G12V 驱动的肿瘤在体内有抑制效力[1]。 TUS-007 即使在原位异种移植模型小鼠中也具有抗肿瘤活性[1]。 Animal Model: Immunodeficient mice bearing SW620-Luc cells[1] Dosage: 80 mg/kg or 160 mg/kg Administration: Intraperitoneal injection or oral gavage; once every 3 days for 21 days Result: Significantly attenuated tumor progression without affecting body weight.
References

[1]. Imanishi S, et al. In vivo KRAS G12D/V degradation mediated by CANDDY using a modified proteasome inhibitor. bioRxiv, 2021: 2021.04. 23.441075.

Molecular Formula C44H54Cl2N8O5
Molecular Weight 845.86